Brooke is an associate editor for The American Journal of Managed Care® (AJMC®). She joined AJMC in 2023, where she produces written content covering multiple disease states.
She has a BA in journalism from Seton Hall University. You can connect with Brooke on LinkedIn.
Theory-Based Smoking Cessation Interventions Positively Affect Patients With COPD Who Smoke
Theory-based smoking cessation interventions helped to motivate patients with chronic obstructive pulmonary disease (COPD) who smoke to quit, ultimately improving their quality of life and lung function.
Cost Burden of Hospital-Onset CDI Higher Than Community-Associated CDI
Researchers found that costs were highest for those with hospital-onset clostridioides difficile infection (CDI), lower for those with community onset-health care facility association CDI, and lowest for those with community-associated CDI.
Dr Sara Horst Defines Digital Health and Its Benefits for Clinicians, Patients
Sara Horst MD, MPH, FACG, discussed how she helps make the electronic medical record more accessible and easier for clinicians to use within her roles as ambulatory director of VUMC Telehealth and Specialty Pharmacy and associate vice chair of Digital Health Operations of the Department of Medicine.
COPD Exacerbations More Common in Unmedicated Patients, but Many Remain Untreated
Most chronic obstructive pulmonary disease (COPD) exacerbations were observed in those not treated with controller medications, but less than half of patients in the study received controller medications, even after exacerbations.
Patients Have Low Risk of Sexually Transmitting HIV With Viral Loads Less Than 1000 Copies/mL
Evidence shows almost zero risk of sexual transmission when HIV viral loads are less than 1000 copies/mL, which could allow providers to destigmatize HIV and promote antiretroviral therapy adherence.
Age, Race, and Ethnicity Representation Disparities Found in Patients Participating in aRCC Research
Researchers discovered age, race, and ethnicity representation disparities in patients taking part in research on advanced renal cell carcinoma (aRCC), further exemplifying how certain groups are underrepresented in clinical studies.